Takahashi Ichiro, Nochi Tomonori, Yuki Yoshikazu, Kiyono Hiroshi
Department of Mucosal Immunology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan.
Curr Opin Immunol. 2009 Jun;21(3):352-8. doi: 10.1016/j.coi.2009.04.002. Epub 2009 Jun 1.
Progress in the past quarter-century on understanding the molecular, cellular, and in vivo components of the mucosal immune system have allowed us to develop a practical strategy for a novel mucosal vaccine. The mucosal immune system can induce secretory IgA (SIgA) and serum IgG responses to provide two layers of defense against mucosal pathogens. For SIgA-mediated immunity in the gastrointestinal tract, the gut-associated lymphoid tissue contains both the tissue-dependent and tissue-independent IgA components. Harnessing the mucosal immune system for vaccine development may help prevent the global health problems caused by enteric infectious diseases. We have therefore combined mucosal immunology and plant biology to create a rice-based mucosal vaccine that requires neither needles and syringes nor refrigeration.
在过去二十五年里,我们对黏膜免疫系统的分子、细胞和体内组成部分的理解取得了进展,这使我们能够制定一种实用的新型黏膜疫苗策略。黏膜免疫系统可诱导分泌型IgA(SIgA)和血清IgG反应,为抵御黏膜病原体提供两层防御。对于胃肠道中SIgA介导的免疫,肠道相关淋巴组织同时包含组织依赖性和组织独立性IgA成分。利用黏膜免疫系统进行疫苗开发可能有助于预防由肠道传染病引起的全球健康问题。因此,我们将黏膜免疫学与植物生物学相结合,研发出一种基于水稻的黏膜疫苗,这种疫苗既不需要针头和注射器,也不需要冷藏。